You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 26 to 50 of about 5856
Next 25
11/08/2024
Musella Foundation Brain Tumor Treatment Copayment Assistance program is open!
11/03/2024
NuvOx Announces Two New Publications
Novocure Announcement
What would I do if diagnosed with a Glioblastoma?
10/20/2024
The EP3-ZNF488 Axis Promotes Self-Renewal of Glioma Stem-like Cells to Induce Resistance to Tumor Treating Fields
Financial toxicity in patients with glioblastoma
Recent advances in Tumor Treating Fields (TTFields) therapy for glioblastoma
10/13/2024
Radiopharmaceutical therapy shows favorable results for people with tough-to-treat meningioma brain tumors, Mayo Clinic study finds
MAGIC-G1 Study Provides Updated Findings With MTX110 in Recurrent Glioblastoma
10/07/2024
MRI Provides Early Warning System for Glioblastoma Growth
09/30/2024
Upcoming presentation at EANO on mycophenolate mofetil (MMF)
Request for Brain Tumor Survivor Stories
Systematic Review and Clinical Insights: The Role of the Ketogenic Diet in Managing Glioblastoma in Cancer Neuroscience
09/23/2024
Antidepressant shows promise for treating brain tumors
09/18/2024
Share Your Experiences With Glioblastoma Multiforme (GBM)
08/26/2024
Boy, 11, denied life-extending drug as his incurable `octopus tumour` is 1 millimetre too small
Metabolic signatures derived from whole-brain MR-spectroscopy identify early tumor progression in high-grade gliomas using machine learning
08/15/2024
2025 College Scholarship $ is Available!
08/12/2024
A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine
ACTION ALERT for New York residents - Medicaid coverage for Tumor Treating Fields
Vorasidenib Approved by FDA for Grade 2 IDH-Mutant Glioma
Musella Foundation Brain Tumor Treatment Copayment Assistance Program is now closed to new patients
08/05/2024
Musella Foundation Brain Tumor Treatment Copayment Assistance program is almost closed
Machine Learning-Directed Conversion of Glioblastoma Cells to Dendritic Cell-like Antigen-Presenting Cells as Cancer Immunotherapy
07/22/2024
Duke Phase 2 poliovirus trial for recurrent glioblastoma open for enrollment